Thyroid Eye Disease (TED) Market Anticipated To Witness Robust Growth, Surpassing 2.96 Billion By 2029

We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

What Is the Current Thyroid Eye Disease (TED) Market Size and Its Estimated Growth Rate?
Over the past few years, the market for thyroid eye disease (TED) has seen significant growth. Predictions indicate that it will increase from $2.15 billion in 2024 to $2.30 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 7.0%. This upsurge in the historical period can be linked to the rise in thyroid disorders, a heightened emphasis on care centred on the patient, a surge in demand for cosmetic procedures, a growing prevalence of the disease, and the increase in treatment options for TED.

Predictions indicate a robust expansion of the thyroid eye disease (TED) market in the coming years, culminating in a market value of $2.97 billion by 2029, bolstered by a compound annual growth rate (CAGR) of 6.6%. Factors pushing this growth over the projected period include rising incidences of Graves' disease, augmented funding across diverse sectors, increasing healthcare investment, proliferating use of thyroid hormone replacement therapy, and an escalation in thyroid disease cases. Prominent trends anticipated throughout this forecast period encapsulate technological progression, expanded research and development activities, the advent of innovative medicines, forward steps in treatment alternatives, and the introduction of new surgical procedures.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21300

How Are Emerging Segments Shaping the Thyroid Eye Disease (TED) Market Landscape?
The thyroid eye disease (TED) market covered in this report is segmented -

1) By Treatment Type: Medical, Surgical, Combination Of Medical And Surgical
2) By Disease Severity: Mild, Moderate, Severe
3) By Drug Type: Biologics, Small Molecules, Others Drug Type
4) By Route Of Administration: Oral, Intravenous, Subcutaneous
5) By End User: Hospitals, Clinics, Other End Users

Subsegments:
1) By Medical: Corticosteroids, Teprotumumab, Antithyroid Medications, Other Medical Treatments
2) By Surgical: Orbital Decompression Surgery, Eyelid Surgery, Strabismus Surgery
3) By Combination Of Medical and Surgical: Combination of Corticosteroids and Orbital Decompression, Combination of Teprotumumab and Eyelid Surgery, Other Combined Approaches

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21300&type=smp

Which Growth Factors Are Influencing Thyroid Eye Disease (TED) Market Expansion?
The growth of the Thyroid Eye Disease (TED) market is anticipated to be fuelled by escalating instances of thyroid disorders. These disorders are medical conditions that disrupt the functioning of the thyroid gland, leading to hormonal imbalances and resulting diseases such as hypothyroidism, hyperthyroidism, goiter, and thyroid eye disease. The increasing occurrence of thyroid problems is attributed to factors like higher iodine intake, autoimmune conditions, genetic vulnerability, and enhanced consciousness leading to better diagnostic rates. Thyroid Eye Disease (TED) is adding to the mounting cases of thyroid disorders as it is a prevalent and severe complication of Graves' disease, which heightens the overall load and cognizance of thyroid-related diseases. For example, the Canadian Cancer Society, a non-profit, community-based organization in Canada, predicted that about 6,600 new cases of thyroid cancer, along with roughly 280 deaths are projected for 2024. Hence, the thriving thyroid disorders are fuelling the expansion of the thyroid eye disease (TED) market.

Who Are the Dominant Players Across Different Thyroid Eye Disease (TED) Market Segments?
Major companies operating in the thyroid eye disease (TED) market are Hoffmann-La Roche AG, Amgen Inc., Genentech Inc., Horizon Therapeutics plc, Pierre Fabre S.A., Innovent Biologics Inc., ACELYRIN Inc., Soleo Health, Zai Lab Limited, HanAll Biopharma Co. Ltd., Tourmaline Bio Inc., Zenas BioPharma Inc., Immunovant Inc., Verana Health, Harbour BioMed (Guangzhou) Co. Ltd., Sling Therapeutics Inc., Crinetics Pharmaceuticals Inc., Lassen Therapeutics Inc., Viridian Therapeutics Inc., Minghui Pharmaceutical Inc.

What Are the Major Trends Shaping the Thyroid Eye Disease (TED) Market?
Leading organizations in the thyroid eye disease (TED) market are concentrating their efforts on delivering innovative products like monoclonal antibody therapies. These therapies aim to create more efficient treatments tailored to reduce inflammation, rectify proptosis, and improve the overall health outcomes of patients. Such therapies utilize lab-created antibodies, which are designed to imitate the body's immune system's specific targeting and neutralization mechanisms of pathogens or abnormal cells. An example of this is the announcement made by Amgen Inc., a biotech firm based in the U.S., in September 2024. The company declared that TEPEZZA (teprotumumab) had received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for use in active TED treatment. This disease is a unique, potentially vision-impairing autoimmune disorder. TEPEZZA is the only FDA-approved therapy uniquely for TED, offering a specially targeted treatment that aids in reducing inflammation, swelling, and other severe symptoms related to the disease. Importantly, this approval brings a fresh, effective treatment option for Japanese patients suffering from TED, a rare progressive disorder causing serious issues like eye bulging, vision impairments, and eye pain.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/thyroid-eye-disease-ted-global-market-report

Which Geographic Regions Are Expected to Dominate the Thyroid Eye Disease (TED) Market in the Coming Years?
North America was the largest region in the thyroid eye disease (TED) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thyroid eye disease (TED) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Thyroid Eye Disease (TED) Market?
2. What is the CAGR expected in the Thyroid Eye Disease (TED) Market?
3. What Are the Key Innovations Transforming the Thyroid Eye Disease (TED) Industry?
4. Which Region Is Leading the Thyroid Eye Disease (TED) Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.